Introduction

Gene expression is one of the most complex and tightly controlled processes within eukaryotic cells. Cellular fate  and indeed the survival of entire organisms crucially depend on precise spatiotemporal coordination of a multitude of genes.

Thus, in the last years there have been several approaches aiming to provide spatial control over gene expression, including  optogentic tools, which are to date the method of choice to control gene expression with  spatio-temporal resolution. For each gene to be expressed by light induction, a  construct containing this gene under control of a light inducible promoter has first to be introduced into the cells. This limits optogentic methods regarding the variability and anzahl of genes to be inserted and controled and makes the procedure time-consuming.

In contrast,  a large variety of differnt genes can easily been packed and delivered by viral vectors. However, gene delivery with viral vectors is unspecific and lacks the ability of targeting specific subpopulations of cells for transduction.

For the past ? month our team developed a novel apllication, called The ACELLerator, which combines the  advantages of both approaches. We use a blue light inducible gene expression system, which mediates   spatial  control and a MuLV based viral vector that provides an easy way to insert any gene cargo. This combination allows to overcome the drawbacks of both approaches and  allows delivery of exogenous genes and also control of endogenous genes, both with high spatial resolution.

The principle of The AcCELLarator and how the components work together is briefly described below.

Optogenetics, a novel technology that allows temporal and spatial induction of gene expression by the use of light, is of growing importance for fundamental research and clinical applications. However, its biggest limitation is the time consuming introduction of transgenes into organisms or cell lines. In contrast, easy but unspecific gene delivery can be achieved by viral vectors. We, the iGEM Team Freiburg 2014, combine the advantages of both approaches – the temporal and spatial resolution of optogenetics, and the simplicity of gene transfer offered by viruses.

To this end we designed a system where the entry of a virus is enabled or prevented by exposing the target cells to light of distinct wavelengths.

In principle, the AcCELLerator bridges the gap between both systems by the light induced expression of a receptor that serves as the entry point for the virus. The components of the system and how they work together are briefly presented below.

Light induced expression of target genes bases on a system that consists of mainly two parts: One, a complex of LOV2 fused to Gal4DBD constantly located  at a specific DNA sequence, the Gal4UAS. While in the dark, Jα chain is not exposed, therefore the ePDZ-VP-16 domain can not be recruited and there is no detectable gene expression.

Upon illumination, the Jα chain of the LOV2-domain becomes accessible enabling the second part of the light system, epdZ fused toVP16, to bind to the Jα chain. The VP-16 domain of the second part acts as a transactivator of transcription that recruits DNA polymerase to the target gene.

Viral vectors constitute a fast and easy to use method of gene delivery. By using viral vectors it is possible to deliver and express a certain gene cargo within only four days. In order to ensure safety and enable the insertion of large gene cargos, essential viral genes are transferred to a so-called packaging cell line. This cell line can afterwards produce infectious viral particles easily, if it is transfected with a transfer vector carrying the gene of interest.

The receptor represents the key component of the AcCELLerator that is essential for the combination of viral vectors and light induced expression systems: Only, if the receptor is present on cells, the virus is able to infect them and insert the gene of interest. Otherwise, the virus can not enter the cell.

Without illumination the cells are in a dormant state and cannot be infected by the viral vector. Upon exposure to the appropriate wavelength, they start expressing the viral entry receptor CAT-1. Addition of the viral vector to the culture medium leads to infection of the activated subset of cells.